Why Glasgow? Why Now?
Glasgow in the European Context
- Strengths for us as European Investors: Positioned as a gateway to the UK and broader EU markets. Stable regulatory framework post-Brexit, with opportunities for innovation and partnerships
- Scottish Government Strategy
- Comparative Analysis: Key differences in costs, talent availability, and growth potential versus hubs like London, Cambridge, and Oxford
- Ability to attract inward investment and collaborate internationally across multiple sectors, not just real estate
- Focus on growth sectors: Precision Medicine, Cancer Research, Infectious Diseases and Virology, Regenerative Medicine and Stem Cell Research, Veterinary and Animal Health Sciences
Why Glasgow?
- Thriving Life Science Ecosystem
- Glasgow Riverside Innovation District (GRID)
- High graduate retention rate – 51%
- Skilled workforce
- Core infrastructure
- Affordability (compared with the Golden Triangle) for SMEs
- Quality of life
- Cultural vibrancy
- Growing population
- Educational hub for Scotland
- Accommodation availability (compared with the Golden Triangle) for workers
- Over 44,000 students in STEM fields across the universities
- Proven track record of innovation
- Queen Elizabeth University Hospital is the largest critical care complex in Western Europe
Why Now?
- Record investment in life sciences in Scotland, already meeting its target of £8 billion turnover by 2025.
- Health Innovation Hub supporting the city to create world-class lab and innovation space.
- A thriving talent pipeline from leading universities and research institutions.
- Strong government support through incentives, grants, and R&D tax relief.
